Drugs, Diagnostics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,392
NCT06994130
Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis
Phase: N/A
Role: Lead Sponsor
Start: Aug 31, 2025
Completion: Aug 31, 2029
Loading map...